Jianfeng Yu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Jianfeng Yu has a total of 11 co-authors. Here are the top co-authors by number of shared publications:
- Dawei Li
Center for Translational Medicine, The Affiliated Zhangjiagang Hospital of Soochow University, 68 Jiyang West Road, Suzhou, 215600, China
47 shared publications - Jieru Zhang
Center for Translational Medicine, The Affiliated Zhangjiagang Hospital of Soochow University, Suzhou Medical College of Soochow University, Suzhou, China
47 shared publications - Jun Zhang
China Pharmaceutical University 4 School of Life Science and Technology, State Key Laboratory of Natural Medicines Nanjing, China
47 shared publications - Jun Zhou
School of Life Science and Technology, China Pharmaceutical University, Nanjing 211198, China; State Key Laboratory of Natural Medicines, China Pharmaceutical University, Nanjing 211198, China; Jiangsu Key Laboratory of Drug Design and Optimization, China Pharmaceutical University, Nanjing 211198, China
47 shared publications - Lifan Su
Center for Translational Medicine, The Affiliated Zhangjiagang Hospital of Soochow University, Suzhou Medical College of Soochow University, Suzhou, China
47 shared publications - Wei Gu
Institute for Cancer Genetics, and Herbert Irving Comprehensive Cancer Center, Vagelos College of Physicians & Surgeons, Columbia University, New York, USA
47 shared publications
Latest Publications
- Open Access
- 4 August 2026
- Published by American Association for Cancer Research (AACR)
Figure S7 from MPND Loss Epigenetically Activates TGFβ/SMAD3 Signaling to Drive Tumor Progression and Metastasis in Non–Small Cell Lung Cancer
Western blotting analysis of MPND protein expression in the indicated NSCLC cell lines
- 4 August 2026
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S7 from MPND Loss Epigenetically Activates TGFβ/SMAD3 Signaling to Drive Tumor Progression and Metastasis in Non–Small Cell Lung Cancer
Western blotting analysis of MPND protein expression in the indicated NSCLC cell lines
- Open Access
- 4 August 2026
- Published by American Association for Cancer Research (AACR)
Figure S9 from MPND Loss Epigenetically Activates TGFβ/SMAD3 Signaling to Drive Tumor Progression and Metastasis in Non–Small Cell Lung Cancer
Cell viability assays of parental and MPND knockout cells
- 4 August 2026
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S9 from MPND Loss Epigenetically Activates TGFβ/SMAD3 Signaling to Drive Tumor Progression and Metastasis in Non–Small Cell Lung Cancer
Cell viability assays of parental and MPND knockout cells
- Open Access
- 4 August 2026
- Published by American Association for Cancer Research (AACR)
Figure S17 from MPND Loss Epigenetically Activates TGFβ/SMAD3 Signaling to Drive Tumor Progression and Metastasis in Non–Small Cell Lung Cancer
MPND controls stemness in H1975 cells via the TGF-β/SMAD3 pathway
- 4 August 2026
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S17 from MPND Loss Epigenetically Activates TGFβ/SMAD3 Signaling to Drive Tumor Progression and Metastasis in Non–Small Cell Lung Cancer
MPND controls stemness in H1975 cells via the TGF-β/SMAD3 pathway
- Open Access
- 4 August 2026
- Published by American Association for Cancer Research (AACR)
Table S15 from MPND Loss Epigenetically Activates TGFβ/SMAD3 Signaling to Drive Tumor Progression and Metastasis in Non–Small Cell Lung Cancer
IHC staining for SMAD3 and p-SMAD3 in HLugA150CS04 LUAD tissue microarray
- 4 August 2026
- Published by American Association for Cancer Research (AACR)
Open AccessTable S15 from MPND Loss Epigenetically Activates TGFβ/SMAD3 Signaling to Drive Tumor Progression and Metastasis in Non–Small Cell Lung Cancer
IHC staining for SMAD3 and p-SMAD3 in HLugA150CS04 LUAD tissue microarray
- Open Access
- 4 August 2026
- Published by American Association for Cancer Research (AACR)
Figure S29 from MPND Loss Epigenetically Activates TGFβ/SMAD3 Signaling to Drive Tumor Progression and Metastasis in Non–Small Cell Lung Cancer
Increased p-SMAD3 expression in LUAD tumor tissues
- 4 August 2026
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S29 from MPND Loss Epigenetically Activates TGFβ/SMAD3 Signaling to Drive Tumor Progression and Metastasis in Non–Small Cell Lung Cancer
Increased p-SMAD3 expression in LUAD tumor tissues
- Open Access
- 4 August 2026
- Published by American Association for Cancer Research (AACR)
Table S10 from MPND Loss Epigenetically Activates TGFβ/SMAD3 Signaling to Drive Tumor Progression and Metastasis in Non–Small Cell Lung Cancer
ChIP-seq analysis of differential H2A K119ub peaks in parental and MPND knockout cells
- 4 August 2026
- Published by American Association for Cancer Research (AACR)
Open AccessTable S10 from MPND Loss Epigenetically Activates TGFβ/SMAD3 Signaling to Drive Tumor Progression and Metastasis in Non–Small Cell Lung Cancer
ChIP-seq analysis of differential H2A K119ub peaks in parental and MPND knockout cells
- Open Access
- 4 August 2026
- Published by American Association for Cancer Research (AACR)
Figure S27 from MPND Loss Epigenetically Activates TGFβ/SMAD3 Signaling to Drive Tumor Progression and Metastasis in Non–Small Cell Lung Cancer
Increased SMAD3 and p-SMAD3 expression in LUAD tissues
- 4 August 2026
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S27 from MPND Loss Epigenetically Activates TGFβ/SMAD3 Signaling to Drive Tumor Progression and Metastasis in Non–Small Cell Lung Cancer
Increased SMAD3 and p-SMAD3 expression in LUAD tissues
- Open Access
- 4 August 2026
- Published by American Association for Cancer Research (AACR)
Figure S5 from MPND Loss Epigenetically Activates TGFβ/SMAD3 Signaling to Drive Tumor Progression and Metastasis in Non–Small Cell Lung Cancer
Decreased expression of MPND in NSCLC tissues
- 4 August 2026
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S5 from MPND Loss Epigenetically Activates TGFβ/SMAD3 Signaling to Drive Tumor Progression and Metastasis in Non–Small Cell Lung Cancer
Decreased expression of MPND in NSCLC tissues
- Open Access
- 4 August 2026
- Published by American Association for Cancer Research (AACR)
Figure S20 from MPND Loss Epigenetically Activates TGFβ/SMAD3 Signaling to Drive Tumor Progression and Metastasis in Non–Small Cell Lung Cancer
Genome-wide effects of MPND loss on H2A K119ub and H2B K120ub as well as gene transcription
- 4 August 2026
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S20 from MPND Loss Epigenetically Activates TGFβ/SMAD3 Signaling to Drive Tumor Progression and Metastasis in Non–Small Cell Lung Cancer
Genome-wide effects of MPND loss on H2A K119ub and H2B K120ub as well as gene transcription
- Open Access
- 4 August 2026
- Published by American Association for Cancer Research (AACR)
Figure S6 from MPND Loss Epigenetically Activates TGFβ/SMAD3 Signaling to Drive Tumor Progression and Metastasis in Non–Small Cell Lung Cancer
Percentage distribution of MPND IHC staining intensity scores in non-cancerous lung tissues compared with LUAD and LUSC tissues
- 4 August 2026
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S6 from MPND Loss Epigenetically Activates TGFβ/SMAD3 Signaling to Drive Tumor Progression and Metastasis in Non–Small Cell Lung Cancer
Percentage distribution of MPND IHC staining intensity scores in non-cancerous lung tissues compared with LUAD and LUSC tissues